Geneseeq
geneseeq.com
Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
LAV
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Backed byfrom the funds' portfolios and accelerator catalogs
LAV Overview
世和基因是中国肿瘤精准医学倡行者，致力于高通量测序技术的临床转化应用，主要面向肿瘤患者开展基因检测，通过明确基因分型指导临床用药选择、提示耐药机制、监测术后复发，同时探索高风险人群早筛早诊，为肿瘤精准医疗提供分子诊断服务和产品。.
News
Geneseeq Canada Named First Genomic Testing Partner in UHN
Geneseeq Technology Inc. (Geneseeq Canada) is pleased to announce its support of cancer research initiatives at University Health Network (UHN), Canada
Read more
Report
Geneseeq Unveils Groundbreaking Blood Test for Early Detection of Pancreatic Cancer
Geneseeq Technology Inc., in collaboration with leading clinical institutions, has developed a cutting-edge blood-based screening test that could transform early detection of pancreatic cancer-potentially saving by identifying the disease at more treatabl
Read more
Report
Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab
/CNW/ - Geneseeq is teaming up with Hospital de Base in Sao José do Rio Preto, Brazil to build an NGS-based precision oncology diagnostic lab in-house to...
Read more
Report
Geneseeq enters collaboration with Illumina to develop comprehensive in-vitro diagnostic NGS kits for cancer
Geneseeq enters collaboration with Illumina to develop comprehensive in-vitro diagnostic NGS kits for cancer
Read more
Report
Geneseeq Inks Deal with Illumina to Develop and Commercialize Comprehensive Cancer In-vitro Diagnostic NGS Kit in China
-Next-generation sequencing- based precision oncology provider Geneseeq Technology Inc., will collaborate with Illumina, Inc. to develop comprehensive in-vitro diagnostic NGS testing kits for cancer, using Illumina's NextSeq 550 Dx sequencing platform. In
Read more
Report